BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 7584018)

  • 1. Screening for colorectal cancer.
    Mandel JS
    Curr Opin Gen Surg; 1994; ():79-84. PubMed ID: 7584018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and economic impact of screening for colorectal cancer by mass fecal occult blood testing.
    Helm JF; Russo MW; Biddle AK; Simpson KN; Ransohoff DF; Sandler RS
    Am J Gastroenterol; 2000 Nov; 95(11):3250-8. PubMed ID: 11095350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for rectal cancer.
    St John DJ
    Hepatogastroenterology; 2000; 47(32):305-9. PubMed ID: 10791177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mass screening for colorectal cancer].
    Faivre J; Tazi MA; Launoy G
    Rev Epidemiol Sante Publique; 1996; 44 Suppl 1():S7-14. PubMed ID: 8935859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of various screening and surveillance methods in colorectal carcinoma].
    Burchert A; Schmassmann A
    Schweiz Med Wochenschr; 1998 Jun; 128(25):999-1011. PubMed ID: 9691335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Randomized controlled trial of sequence mass screening program for colorectal cancer].
    Liu X; Zheng S; Chen K; Ma X; Zhou L; Yu H; Yao K; Chen K; Cai S; Zhang S
    Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Dec; 21(6):430-3. PubMed ID: 11860828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Periodic health examination, 1994 update: 2. Screening strategies for colorectal cancer. Canadian Task Force on the Periodic Health Examination.
    Solomon MJ; McLeod RS
    CMAJ; 1994 Jun; 150(12):1961-70. PubMed ID: 7980760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer.
    Lindholm E; Brevinge H; Haglind E
    Br J Surg; 2008 Aug; 95(8):1029-36. PubMed ID: 18563785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for colorectal cancer. Use of a new protocol may reduce death rates.
    Lush DT
    Postgrad Med; 1994 Jul; 96(1):99-106. PubMed ID: 8022720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent developments in colorectal cancer screening and prevention.
    Pignone M; Levin B
    Am Fam Physician; 2002 Jul; 66(2):297-302. PubMed ID: 12152966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevention of colorectal carcinoma. Annual hemoccult test and sigmoidoscopy every 5 years].
    Rosenbaum A; Riemann JF
    MMW Fortschr Med; 2000 Aug; 142(31-32):27-9. PubMed ID: 10992763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recommendations on population screening for colorectal cancer in New Zealand. Members of the National Health Committee Working Party on Population Screening for Colorectal Cancer.
    N Z Med J; 1999 Jan; 112(1080):4-6. PubMed ID: 10073156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for colorectal cancer screening.
    Bretthauer M
    Best Pract Res Clin Gastroenterol; 2010 Aug; 24(4):417-25. PubMed ID: 20833346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival of patients diagnosed with colorectal cancer through a television-advertised screening program.
    Slusser SO; Liberski SM; McGarrity TJ
    Am J Gastroenterol; 1996 Aug; 91(8):1563-6. PubMed ID: 8759662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
    Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
    J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study.
    Mandel JS; Bond JH; Church TR; Snover DC; Bradley GM; Schuman LM; Ederer F
    N Engl J Med; 1993 May; 328(19):1365-71. PubMed ID: 8474513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fecal occult blood testing and the incidence of colorectal cancer.
    Singer RB
    J Insur Med; 2002; 34(2):89-91. PubMed ID: 15305783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for colorectal cancer--United States, 1992-1993, and new guidelines.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Feb; 45(5):107-10. PubMed ID: 8592492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal cancer: risk factors and recommendations for early detection.
    Read TE; Kodner IJ
    Am Fam Physician; 1999 Jun; 59(11):3083-92. PubMed ID: 10392591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fecal occult blood test and mass screening for colorectal cancer].
    Saito H; Soma Y; Kawaguchi H
    Gan To Kagaku Ryoho; 1991 Oct; 18(13):2232-40. PubMed ID: 1929443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.